Blood Biomarkers and Heart Function in Tetralogy of Fallot
Author Information
Author(s): van Genuchten Wouter J., van den Bosch Eva, Luijnenburg Saskia E., Kamphuis Vivian P., Roos-Hesselink Jolien W., Bartelds Beatrijs, Roest Arno A.W., Breur Johannes M.P.J., Blom Nico A., Boersma Eric, Koopman Laurens P.
Primary Institution: Erasmus University Medical Center
Hypothesis
Changes in blood biomarkers correlate with changes in biventricular size and function in patients with tetralogy of Fallot.
Conclusion
In clinically stable ToF patients, changes in right and left ventricular size and function correlated with alterations in blood biomarkers of inflammation and immune response to stress.
Supporting Evidence
- Significant correlations were observed between changes in right ventricular size and changes in NT-proBNP, ST-2, GDF-15, IGFBP7, and FABP-4.
- Correlations with NT-proBNP were driven by changes in right ventricular size induced by pulmonary valve replacement.
- Increases in left ventricular mass were correlated to decreases in NT-proBNP.
Takeaway
This study found that when the heart size and function change in patients with a specific heart condition, the levels of certain blood markers also change, which can help doctors understand how the heart is doing.
Methodology
The study included 50 ToF patients who underwent blood biomarker and cardiac magnetic resonance imaging (CMR) analysis at least twice between 2002 and 2018.
Limitations
The sample size was relatively small, limiting the power to detect smaller correlations and preventing separate analysis of the PVR group.
Participant Demographics
68% of the patients were male, with an average age of 16.1 years at the first visit.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website